Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model

BACKGROUND: Availability of an ultra-short-course drug regimen capable of curing patients with tuberculosis in 2 to 3 mo would significantly improve global control efforts. Because immediate prospects for novel treatment-shortening drugs remain uncertain, we examined whether better use of existing d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rosenthal, Ian M, Zhang, Ming, Williams, Kathy N, Peloquin, Charles A, Tyagi, Sandeep, Vernon, Andrew A, Bishai, William R, Chaisson, Richard E, Grosset, Jacques H, Nuermberger, Eric L
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2007
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2140085/
https://ncbi.nlm.nih.gov/pubmed/18092886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0040344
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados